[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>William N. Hait<\/i><\/u><\/presenter>. Johnson & Johnson Pharmaceutical R&D, New Brunswick, NJ","CSlideId":"","ControlKey":"a2e8a88f-5951-4e77-b117-0f8695774a26","ControlNumber":"10965","DisclosureBlock":"","End":"4\/16\/2023 5:31:00 PM","HasWebcast":null,"Highlights":[],"Id":"10743","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"William Hait, MD;PhD","PresenterKey":"1c3c13f9-3191-4408-a4ce-de8bc718c878","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chairperson","SearchResultFooter":"","SearchResultHeader":"Apr 16 2023  5:30PM","SessionId":"152","SessionOnDemand":"False","SessionTitle":"Presidential Address:&nbsp;Identifying Immune Vulnerabilities in Solid Tumors - Leukocyte Communication Networks Regulate Neoplastic Progression and Response to Therapy","ShowChatLink":"false","Start":"4\/16\/2023 5:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chairperson","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>William N. Hait<\/i><\/u><\/presenter>. Johnson & Johnson Pharmaceutical R&D, New Brunswick, NJ","CSlideId":"","ControlKey":"5b6dbe44-ddda-4f67-a22a-157b3e1ab0b8","ControlNumber":"10966","DisclosureBlock":"","End":"4\/16\/2023 5:35:00 PM","HasWebcast":null,"Highlights":[],"Id":"10744","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"William Hait, MD;PhD","PresenterKey":"1c3c13f9-3191-4408-a4ce-de8bc718c878","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Introduction","SearchResultFooter":"","SearchResultHeader":"Apr 16 2023  5:30PM","SessionId":"152","SessionOnDemand":"False","SessionTitle":"Presidential Address:&nbsp;Identifying Immune Vulnerabilities in Solid Tumors - Leukocyte Communication Networks Regulate Neoplastic Progression and Response to Therapy","ShowChatLink":"false","Start":"4\/16\/2023 5:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Introduction","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Lisa M. Coussens<\/i><\/u><\/presenter>. OHSU Knight Cancer Institute, Portland, OR","CSlideId":"","ControlKey":"0e599622-1c99-42f1-8dbd-d694db651323","ControlNumber":"10955","DisclosureBlock":"<b>&nbsp;L. M. Coussens, <\/b> <br><b>AbbVie Inc.<\/b> I, I, I, I. <br><b>Alkermes, Inc.<\/b> I, I, I, I. <br><b>American Association for Cancer Research<\/b> I, I, I, I. <br><b>AstraZeneca AB<\/b> I, I, I, I. <br><b>Bloomberg-Kimmel Institute for Cancer Immunotherarpy<\/b> I, I, I, I. <br><b>Cancer Research Institute<\/b> I, I, I, I. <br><b>Carisma Therapeutics Inc.<\/b> I, I, I, I. <br><b>Cell Signaling Technologies<\/b> I, I, I, I. <br><b>Columbia University Medical Center<\/b> I, I, I, I. <br><b>CytomX Therapeutics Inc.<\/b> I, I, I, I. <br><b>Dana Farber Cancer Center Breast SPORE<\/b> I, I, I, I. <br><b>Dana Farber\/Harvard Cancer Center<\/b> I, I, I, I. <br><b>Genenta Sciences<\/b> I, I, I, I. <br><b>Hibercell, Inc.<\/b> I, G, I, G, I, G, I, G. <br><b>Kineta Inc.<\/b> I, I, I, I. <br><b>Koch Institute for Integrated Cancer Research<\/b> I, I, I, I. <br><b>Lustgarten Foundation<\/b> I, G, I, G, I, G, I, G. <br><b>MDACC GI SPORE<\/b> I, I, I, I. <br><b>NIH\/NCI-Frederick National Laboratory Advisory Committee<\/b> I, I, I, I. <br><b>National Foundation for Cancer Research<\/b> G, G, G, G. <br><b>NextCure<\/b> I, I, I, I. <br><b>PDX Pharmaceuticals, Inc.<\/b> I, I, I, I. <br><b>Pio Therapeutics Pty Ltd<\/b> I, I, I, I. <br><b>Prospect Creek Foundation<\/b> G, G, G, G. <br><b>Shasqi, Inc.<\/b> I, I, I, I. <br><b>Susan G. Komen<\/b> G, G, G, G. <br><b>Susan G. Komen Foundation, Komen Scholar<\/b> I, I, I, I. <br><b>Syndax Pharmaceuticals Inc.<\/b> G, G, G, G. <br><b>The Jackson Laboratory Cancer Center<\/b> I, I, I, I. <br><b>University of California, San Diego Moores Cancer Center<\/b> I, I, I, I. <br><b>Zymeworks, Inc.<\/b> I, I, I, I.","End":"4\/16\/2023 6:15:00 PM","HasWebcast":null,"Highlights":[],"Id":"10733","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Lisa Coussens, PhD","PresenterKey":"28b4c13f-457b-4975-a458-3416b7fce36c","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Identifying immune vulnerabilities in solid tumors: Leukocyte communication networks regulate neoplastic progression and response to therapy","SearchResultFooter":"","SearchResultHeader":"Apr 16 2023  5:30PM","SessionId":"152","SessionOnDemand":"False","SessionTitle":"Presidential Address:&nbsp;Identifying Immune Vulnerabilities in Solid Tumors - Leukocyte Communication Networks Regulate Neoplastic Progression and Response to Therapy","ShowChatLink":"false","Start":"4\/16\/2023 5:35:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Identifying immune vulnerabilities in solid tumors: Leukocyte communication networks regulate neoplastic progression and response to therapy","Topics":null,"cSlideId":""}]